RIVIVE

Naloxone hydrochloride · Harm Reduction Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RIVIVE, covering 2023-07-28 to 2023-07-28. Get the full timeline:

Most recent: FDA Approved: RIVIVE — Original Application (Harm Reduction Therapeutics, Inc.)